Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

Jackson, Doreen; Qiao, Na; Greene, Julia M; Hale, Diane; Berry, John; Trappey, Alfred; Vreeland, Timothy; Clifton, Guy; Ibrahim, Nuhad; Toms, Annie; Peoples, George E; Mittendorf, Elizabeth A

doi:10.1186/2051-1426-3-S2-P156

Article metrics
Last updated: Fri, 26 Apr 2024 4:23:23 Z

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

Access & Citations

800

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.